Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.40 |
| ▸ | KIT | P10721 | 8/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | ABL1 | P00519 | 1/20 | 0.35 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.34 |
| ▸ | SGK1 | O00141 | 4/20 | 0.34 |
| ▸ | PIM1 | P11309 | 1/20 | 0.33 |
| ▸ | PIM2 | Q9P1W9 | 1/20 | 0.33 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.33 |
| ▸ | KMO | O15229 | 1/20 | 0.33 |
| ▸ | KDR | P35968 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11902934 | 0.78 | TRPV1 (0.39) | TRPV1KITCYP1A2ABL1PDE4D | |
| SCHEMBL11917993 | 0.78 | ABL1 (0.37) | TRPV1CYP1A2ABL1PDE4DHDAC6 | |
| SCHEMBL11918060 | 0.77 | MEP1B (0.33) | KIT | |
| SCHEMBL11918068 | 0.73 | ADORA2A (0.37) | — | |
| SCHEMBL12885490 | 0.69 | KMO (0.40) | TRPV1CYP1A2ABL1PDE4DHDAC6 | |
| SCHEMBL11913444 | 0.68 | TRPV1 (0.38) | TRPV1CYP1A2ABL1SGK1 | |
| SCHEMBL12888472 | 0.67 | CYP1A2 (0.42) | TRPV1CYP1A2ABL1PDE4DKMO | |
| SCHEMBL12786040 | 0.66 | GPR68 (0.45) | CYP1A2 | |
| SCHEMBL11918075 | 0.65 | GPR68 (0.44) | CYP1A2 | |
| SCHEMBL11913448 | 0.65 | CYP1A2 (0.38) | TRPV1CYP1A2ABL1PDE4DSGK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120202690-A1 | HERBICIDAL COMPOUNDS | SYNGENTA LIMITED (US) | 2012-08-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120202690-A1 | HERBICIDAL COMPOUNDS | DDT, HAO2, HAAO | TRPV1 2865/4885KIT 4785/4885CYP1A2 75/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.